CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474790334
- Phone
- 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 10,000 shares at an average $0.66 ($6,610)
- 4 Option exercise Director acquired 6,250 shares (option exercise)
- 4 Open-market buy PRESIDENT AND CEO bought 5,000 shares at $0.60 ($3,000)
- 4 Open-market buy Director bought 15,500 shares at $0.74 ($11,470)
- 4 Open-market buy PRESIDENT AND CEO bought 13,500 shares at an average $0.75 ($10,110)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 3,950 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 10,348 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 9,664 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 8,019 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 4,461 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 9,664 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 3,951 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 420,000 shares at $2.50 ($1,050,000)
Page 3 of 9 · 170 filings